Tumor Markers: A Guide to Laboratory Testing
Tumor markers are substances that can be detected in blood, urine, or tissue and may be produced by cancer cells or by the body in response to cancer. They are useful tools in some situations, but they are rarely diagnostic on their own. This guide explains how tumor marker tests work, when they are typically used, what results mean, and why they must always be interpreted alongside imaging, biopsy findings, and your overall clinical picture.
Key takeaways
- Tumor markers are substances measured in blood, urine, or tissue that may be elevated in some cancers, but elevations can also occur in benign conditions.
- Most tumor markers are not used to screen for cancer in people without symptoms because they can produce false positives and false negatives.
- Tumor markers are most often used to monitor response to treatment, detect recurrence, or help support a diagnosis when combined with other tests.
- A single marker result is rarely meaningful on its own; trends over time and the full clinical context matter far more.
- Reference ranges vary by laboratory, so results should be interpreted using the range provided by the lab that performed the test.
What Are Tumor Markers?
Tumor markers are biological substances that can be measured in body fluids or tissue. Some are proteins produced by cancer cells themselves, while others are produced by normal cells in response to the presence of cancer. Examples include CA-125, which is often associated with ovarian cancer; PSA, associated with prostate tissue and prostate cancer; CEA, often associated with colorectal and other cancers; and AFP, associated with liver and germ cell tumors.
These markers are not unique to cancer. Many can rise with inflammation, infection, benign tumors, or other non-cancerous conditions. For example, CA-125 can be elevated in endometriosis or pelvic inflammation, and PSA can rise with benign prostatic enlargement. Because of this overlap, a tumor marker result alone cannot confirm or rule out cancer.
How Tumor Marker Tests Are Used
Tumor markers are most commonly used after a cancer diagnosis has been established, rather than as a first-line screening tool. They can help track how well a treatment is working, detect a recurrence before symptoms appear, or provide supporting information when a biopsy is not feasible. In some cases, a marker is measured before treatment to establish a baseline, then monitored over time to see whether levels are falling, stable, or rising.
In a smaller number of situations, tumor markers may be used alongside imaging to help evaluate a suspicious finding. For instance, a markedly elevated AFP in a person with a liver mass and risk factors may support a diagnosis of hepatocellular carcinoma. Even then, the result is interpreted together with imaging and clinical findings, not in isolation.
Interpreting Results and Limitations
Tumor marker results are reported against a reference range established by the performing laboratory. A value above the range is often described as elevated, but elevation does not automatically mean cancer is present, and a normal value does not guarantee cancer is absent. Some cancers never produce elevated levels of the markers commonly associated with them, which is why a normal result can be falsely reassuring if used alone.
Trends are usually more informative than single measurements. A marker that falls after treatment and then rises months later may prompt further evaluation for recurrence. Conversely, a mildly elevated marker that remains stable over time may be monitored rather than acted upon immediately. Your clinician will consider your history, symptoms, imaging, and other lab results when deciding what a marker value means for you.
Common Tumor Markers and Their Contexts
Several markers are widely known, but each has a specific context. PSA is used in prostate cancer discussions, often alongside digital rectal exam and biopsy decisions. CA-125 is used in ovarian cancer monitoring and sometimes in evaluating pelvic masses. CEA is used mainly in colorectal cancer follow-up. AFP is used in liver cancer and germ cell tumor evaluation. CA 19-9 is used in pancreatic and other gastrointestinal cancers, and CA 15-3 and CA 27.29 are used in breast cancer monitoring.
Each of these markers has different sensitivity and specificity, meaning they perform differently depending on the cancer type and stage. Some are better for monitoring than for detection. Because no marker is perfectly accurate, guidelines generally recommend them as part of a broader assessment rather than as stand-alone tests. Your care team can explain which marker, if any, is appropriate for your situation.
Frequently Asked Questions
Can tumor markers diagnose cancer on their own?
No. Tumor markers are not diagnostic by themselves. Elevated levels can occur in non-cancerous conditions, and normal levels do not rule out cancer. A diagnosis typically requires a biopsy or other tissue evaluation, with tumor markers used as supporting information.
Are tumor markers used for cancer screening in healthy people?
In most cases, no. Routine screening with tumor markers is not recommended for the general population because of false positives and false negatives. A few markers may be used in specific high-risk groups, but this is decided by clinical guidelines and individual risk assessment.
Why do tumor marker reference ranges differ between labs?
Laboratories use different assays, equipment, and calibration methods, so reference ranges can vary. This means a result from one lab may not be directly comparable to a result from another. It is best to compare results performed by the same laboratory over time.
What should I do if my tumor marker result is elevated?
An elevated result is not a diagnosis. Discuss it with your clinician, who will consider your symptoms, history, imaging, and other tests. They may recommend repeat testing, additional imaging, or a biopsy depending on the full picture.
Sources
Ready to get tested? Compare markers, check any fasting guidance, then secure the panel via the RequestALabTest partner at your convenience.
Order Alpha-Fetoprotein (AFP) Tumor Marker TestReviewed by the RequestALabTest Editorial Team
Each laboratory panel is reviewed by the RequestALabTest editorial desk against authoritative reference data.